CURE vs. SOXL
CURE (Direxion Daily Healthcare Bull 3x Shares) and SOXL (Direxion Daily Semiconductor Bull 3X ETF) are both Leveraged Equities funds from Direxion - CURE tracks the Health Care Select Sector Index (300%) while SOXL tracks the ICE Semiconductor Index. Both are passively managed. Over the past 10 years, CURE returned 11.65%/yr vs 65.39%/yr for SOXL. At a 0.47 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 0.75%/yr for SOXL.
Performance
CURE vs. SOXL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a -18.38% return, which is significantly lower than SOXL's 567.48% return. Over the past 10 years, CURE has underperformed SOXL with an annualized return of 11.65%, while SOXL has yielded a comparatively higher 65.39% annualized return.
CURE
- 1D
- 2.17%
- 1M
- 4.39%
- YTD
- -18.38%
- 6M
- -18.70%
- 1Y
- 21.60%
- 3Y*
- -0.15%
- 5Y*
- 0.21%
- 10Y*
- 11.65%
SOXL
- 1D
- 5.34%
- 1M
- 119.95%
- YTD
- 567.48%
- 6M
- 502.28%
- 1Y
- 1,438.30%
- 3Y*
- 135.13%
- 5Y*
- 48.72%
- 10Y*
- 65.39%
CURE vs. SOXL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -18.38% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
SOXL Direxion Daily Semiconductor Bull 3X ETF | 567.48% | 54.91% | -12.31% | 226.98% | -85.66% | 118.84% | 70.04% | 231.83% | -39.07% | 141.71% |
Correlation
The correlation between CURE and SOXL is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.33 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2011 | 0.47 |
Over the past year, the correlation between CURE and SOXL has dropped to 0.15 - well below their long-term average of 0.47, suggesting their price drivers have been diverging.
CURE vs. SOXL - Sectors Allocation Comparison
Sectors
CURE
SOXL
Healthcare
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
CURE
SOXL
-
Basic Materials
CURE
-
SOXL
-
Communication Services
CURE
-
SOXL
-
Consumer Cyclical
CURE
-
SOXL
-
Consumer Defensive
CURE
-
SOXL
-
Energy
CURE
-
SOXL
-
Financial Services
CURE
-
SOXL
-
Industrials
CURE
-
SOXL
-
Real Estate
CURE
-
SOXL
-
Technology
CURE
-
SOXL
Utilities
CURE
-
SOXL
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. SOXL — Risk / Return Rank
CURE
SOXL
CURE vs. SOXL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Semiconductor Bull 3X ETF (SOXL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE | SOXL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -13.78 | ||
| Sortino ratioReturn per unit of downside risk | -4.14 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.72 | -0.60 |
| Calmar ratioReturn relative to maximum drawdown | 0.70 | 33.47 | -32.77 |
| Martin ratioReturn relative to average drawdown | 1.61 | 114.79 | -113.18 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CURE | SOXL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.50 | 14.28 | -13.78 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.00 | 0.46 | -0.45 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.24 | 0.66 | -0.43 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.46 | 0.52 | -0.06 |
Drawdowns
CURE vs. SOXL - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum SOXL drawdown of -90.46%. Use the drawdown chart below to compare losses from any high point for CURE and SOXL.
Loading charts...
Drawdown Indicators
| CURE | SOXL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -90.46% | +21.27% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -43.47% | +12.37% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | -87.88% | +35.95% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | -90.46% | +38.23% |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | -90.46% | +21.27% |
Current DrawdownCurrent decline from peak | -35.21% | 0.00% | -35.21% |
Average DrawdownAverage peak-to-trough decline | -18.15% | -35.01% | +16.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.43% | 12.65% | +0.78% |
Volatility
CURE vs. SOXL - Volatility Comparison
The current volatility for Direxion Daily Healthcare Bull 3x Shares (CURE) is 11.99%, while Direxion Daily Semiconductor Bull 3X ETF (SOXL) has a volatility of 40.82%. This indicates that CURE experiences smaller price fluctuations and is considered to be less risky than SOXL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | SOXL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.99% | 40.82% | -28.83% |
Volatility (6M)Calculated over the trailing 6-month period | 29.83% | 81.29% | -51.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.19% | 102.11% | -58.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.69% | 107.25% | -63.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.51% | 99.04% | -49.53% |
CURE vs. SOXL - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than SOXL's 0.75% expense ratio.
Dividends
CURE vs. SOXL - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.31%, more than SOXL's 0.03% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.31% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% |
SOXL Direxion Daily Semiconductor Bull 3X ETF | 0.03% | 0.34% | 1.18% | 0.51% | 1.07% | 0.04% | 0.05% | 0.38% | 1.30% | 0.09% | 4.84% |
Frequently Asked Questions
CURE and SOXL have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SOXL has higher volatility (40.82%) compared to CURE (11.99%). In terms of maximum drawdown, CURE dropped -69.19% vs SOXL's -90.46%.
On 10-year performance, SOXL leads with 65.39% vs 11.65% for CURE. On fees, SOXL is cheaper at 0.75% per year. On volatility, CURE has been the lower-risk option at 11.99%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SOXL has performed better with a 65.39% return vs 11.65%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SOXL is cheaper with a 0.75% expense ratio, compared with 1.08% for CURE.
CURE has the higher dividend yield at 1.31%, compared with 0.03% for SOXL.
CURE tracks Health Care Select Sector Index (300%), while SOXL tracks ICE Semiconductor Index. Their fees differ too: 1.08% for CURE and 0.75% for SOXL.
SOXL currently has the higher Sharpe Ratio (14.28 vs 0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and SOXL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer